BioWorld22d
EMA’s CHMP recommends Hympavzi for hemophilia, Elahere for cancer
For once, the EMA appears to have pipped the U.S. FDA to the post, with Pfizer Inc.’s hemophilia A and B therapy Hympavzi (marstacimab) recommended for approval in Europe on Sept. 20, while the U.S.
CBS News25d
Drugmakers to stop making controversial fentanyl lollipops, FDA says
"As of the date of this announcement, there are fewer than 150 patients receiving treatment with TIRF medicines," the FDA said in a statement published this week. Patients who are currently on a ...
USA Today17d
This FDA-approved drug promises a new way to treat schizophrenia
People with schizophrenia will have a new treatment option for the first time in more than three decades, after the Food and Drug Administration Thursday approved a new kind of drug. Studies ...
The Hill24d
FDA approves first self-administered flu vaccine
The Food and Drug Administration (FDA) announced Friday it has approved the first flu vaccine that can be self-administered, with this version being a nasal spray as opposed to an injection.
Today4d
FDA says egg recall over salmonella can have 'serious' health effects: Avoid these brands
Is there a recall on eggs? Yes, according to the FDA, there is currently a recall on eggs sold in three states: Wisconsin, Illinois and Michigan. The status of the recall is ongoing, according to ...
Yahoo Finance25d
FDA Declines to Approve Vanda's Marketing Application for Tradipitant in Gastroparesis
On September 18, 2024, the U.S. Food and Drug Administration (FDA) declined to approve Vanda's New Drug Application (NDA) of tradipitant for the treatment of symptoms in gastroparesis, providing ...
Today20d
FDA issues recall notices over 2 brands of pet food due to salmonella and listeria risk
Amid an ongoing pet food recall, the U.S. Food and Drug Administration (FDA) is urging pet owners not to give their dogs and cats certain food products from two different brands. Both the brands ...
Fox News17d
New schizophrenia drug gets FDA approval, taking novel approach to treating brain disorder
On Thursday, the U.S. Food and Drug Administration (FDA) approved COBENFY (xanomeline and trospium chloride), an oral medication that is manufactured by Bristol Myers Squibb in New Jersey.
ABC News18d
FDA approves 1st new drug for schizophrenia in more than 30 years
The medication, Cobenfy, combines two drugs and is taken as a twice-daily pill. The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with ...
TechCrunch27d
Neuralink’s ‘breakthrough device’ clearance from FDA does not mean it has cured blindness
Neuralink, the Elon Musk-owned brain-computer interface company, on Tuesday received “breakthrough device” clearance from the FDA. But this does not mean the outfit has developed a cure for ...
STAT26d
FDA designates devices for heart surgery, smart knee implant as ‘breakthroughs’
The latest medical devices to receive breakthrough status from the Food and Drug Administration range across conditions, with several treating cardio and neurovascular conditions. The FDA’s ...
Salon27d
The FDA wants to place warning labels on food packages to combat obesity and other health conditions
The Food and Drug Administration (FDA) is looking to propose the inclusion of front-of-package warning labels that detail the calorie, fat, sugar and salt content of various processed food and ...